| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700311 NAD and/or NADP-dependent alcohol dehydrogenase for use in preparation of primary and enantiomerically pure secondary alcohol's for use as intermediates in synthesis of medicants |
| 04/20/2010 | US7700310 Method for detecting transferase enzymatic activity |
| 04/20/2010 | US7700306 characterising a polypeptide by matrix assisted laser desorption ionization (MALDI) mass spectrometry; improving sensitivity, and can increase the number of peptides that are detected from a protein |
| 04/20/2010 | US7700304 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 04/20/2010 | US7700301 Using protein tyrosine phosphatase (SHP-2) as tool in identifying compounds which modulate the activity of programed death-1 (PD-1); treating autoimmune, nervous system, tumor and immunosuppressive disorders |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700293 Expression profile of prostate cancer |
| 04/20/2010 | US7700292 diagnostic assays that can be used to determine if a woman carries an allelic form of the HMGA2 gene that predisposes her to the formation of fibroid tumors; high mobility group (HMG) |
| 04/20/2010 | US7700291 using molecular markers for identifying potential bovine carriers of the dwarfism mutation and for identifying the genetic locus and mutations thereof responsible for dwarfism and genetic markers test for assaying for the same |
| 04/20/2010 | US7700290 Method of manufacturing DNA chip |
| 04/20/2010 | US7700289 Method for labeling RNA |
| 04/20/2010 | US7700288 miR-155 assay |
| 04/20/2010 | US7700287 Compositions and methods for terminating a sequencing reaction at a specific location in a target DNA template |
| 04/20/2010 | US7700286 cancer detection assay in plasma/serum measuring by adding and comparing the amount of DNA and RNA of certain genes in the plasma/serum of cancer patients that are the reflection of a gene amplification and a gene over expression |
| 04/20/2010 | US7700285 Recovering the protein expressed by open reading frame 2 from porcine circovirus type 2; provide immunogenic composition that comprises PCV2 ORF2 proteins and that are highly stable over a period of 24 months |
| 04/20/2010 | US7700284 kits that utilize a polynucleotide reporter system to detect activities of multiple trans-acting factors, such as nuclear hormone receptors and transcription factors in biological systems |
| 04/20/2010 | US7700283 use of a reaction mixture that includes a ligase and a cofactor selected from NAD+ or ATP and incubating the polynucleotide with the reaction mixture in the absence of Endonuclease VI |
| 04/20/2010 | US7700282 Method for the carry-over protection in DNA amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids |
| 04/20/2010 | US7700281 Hot start nucleic acid amplification |
| 04/20/2010 | US7700280 Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer |
| 04/20/2010 | US7700279 Assay for bcr/abl gene rearrangement |
| 04/20/2010 | US7700278 Detection of red tide organisms by nucleic acid amplification |
| 04/20/2010 | US7700277 Use of polymorphisms in human OATP-C associated with an effect on statin pharmacokinetics in humans in statin therapy |
| 04/20/2010 | US7700276 pulsing blood cells present in the whole blood sample of step with an identical/similar and/or different immunomodulatory agent as present in the subject using a device or kit; diagnosis/prognosis/monitoring of a clinical status affecting the immune system |
| 04/20/2010 | US7700275 Detection system |
| 04/20/2010 | US7700274 Compositions and methods in cancer associated with altered expression of KCNJ9 |
| 04/20/2010 | US7700273 Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human immunodeficiency virus (HIV) CCR5 coreceptor |
| 04/20/2010 | US7700272 Ligand gated chloride channel for use as screening tool in identifying/screening pesticidal and antiparasitic agents |
| 04/20/2010 | US7700271 Method of diagnosis and treatment and agents useful for same |
| 04/20/2010 | US7700118 Molecular differences between species of the M. tuberculosis complex |
| 04/20/2010 | US7700116 Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane |
| 04/20/2010 | US7700106 Therapeutic agent for ulcerative colitis |
| 04/20/2010 | US7700095 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 04/20/2010 | US7700088 Interleukin-9 mutein peptides |
| 04/20/2010 | US7699967 Analysis implement with opening in insulation film |
| 04/20/2010 | US7699964 Membrane suitable for use in an analyte sensor, analyte sensor, and associated method |
| 04/20/2010 | CA2432363C Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| 04/20/2010 | CA2400954C Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions |
| 04/20/2010 | CA2394948C Screen-printable paste for producing a porous polymer membrane for a biosensor |
| 04/20/2010 | CA2373389C Container having corner support |
| 04/20/2010 | CA2358925C Compositions and methods for use in targeting vascular destruction |
| 04/20/2010 | CA2332701C Medium and matrix for long-term proliferation of cells |
| 04/20/2010 | CA2330549C Diacylglycerol o-acyltransferase |
| 04/20/2010 | CA2329476C Ready-to-use ristocetin cofactor test reagent possessing long-term stability |
| 04/20/2010 | CA2318486C Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 04/20/2010 | CA2219876C Stable variant hk2 polypeptide |
| 04/17/2010 | CA2683207A1 Determination of melting temperatures by equation-less methods |
| 04/17/2010 | CA2682439A1 Cell monitoring and molecular analysis |
| 04/15/2010 | WO2010042943A1 Tunable hydrogel microparticles |
| 04/15/2010 | WO2010042921A1 Gpcr arrestin assays |
| 04/15/2010 | WO2010042865A2 Non-transgenic tomato varieties having increased shelf life post-harvest |
| 04/15/2010 | WO2010042831A2 Diagnosis, prognosis and treatment of glioblastoma multiforme |
| 04/15/2010 | WO2010042800A1 Methods of reprogramming somatic cells and methods of use for such cells |
| 04/15/2010 | WO2010042765A1 Ca9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma |
| 04/15/2010 | WO2010042716A1 Genetic alterations associated with type i diabetes and methods of use thereof for diagnosis and treatment |
| 04/15/2010 | WO2010042669A2 Co-culture compositions and methods |
| 04/15/2010 | WO2010042637A2 Bead incubation and washing on a droplet actuator |
| 04/15/2010 | WO2010042551A2 Methods for providing cellular lysates from cell wall-containing samples |
| 04/15/2010 | WO2010042520A1 Methods of characterizing breast cancer and identifying treatments for same |
| 04/15/2010 | WO2010042370A1 Methods for detecting dihydrotestosterone by mass spectrometry |
| 04/15/2010 | WO2010042228A2 Methods for predicting disease outcome in patients with colon cancer |
| 04/15/2010 | WO2010042138A1 System for capturing & modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 04/15/2010 | WO2010042102A1 Identification of subjects likely to benefit from copper treatment |
| 04/15/2010 | WO2010042007A1 Method for the mapping of the local at/gc ratio along dna |
| 04/15/2010 | WO2010041755A1 METHOD FOR MEASURING SURVIVIN mRNA |
| 04/15/2010 | WO2010041715A1 Novel fructosyl peptide oxidase |
| 04/15/2010 | WO2010041459A1 Method for quantitative analysis of drug metabolite and analyzer |
| 04/15/2010 | WO2010041444A1 Method for detecting integron, method for detecting integron pollution in the environment, and primer pair |
| 04/15/2010 | WO2010041419A1 Novel protein having fructosyl valyl histidine oxidase activity and modified product thereof, and use of the protein or the modified product |
| 04/15/2010 | WO2010041232A2 A method of estimating sepsis risk in an individual with infection |
| 04/15/2010 | WO2010041149A2 Methods and compositions for diagnosis and treatment |
| 04/15/2010 | WO2010041088A1 Microfluidic apparatus and method for dna extraction, amplification and analysis |
| 04/15/2010 | WO2010041078A1 Holographic sensor and its use in the detection of enzyme inhibition |
| 04/15/2010 | WO2010040952A2 Reaction medium for staphylococcus aureus bacteria |
| 04/15/2010 | WO2010040951A1 Reaction medium for methicillin-resistant staphylococcus aureus (mrsa) bacteria |
| 04/15/2010 | WO2010040920A2 Device for cell culture |
| 04/15/2010 | WO2010040872A1 Method for determining the contribution of biomass to cod |
| 04/15/2010 | WO2010040851A2 Microfluidic multiplexed cellular and molecular analysis device and method |
| 04/15/2010 | WO2010040831A1 Genetic analysis in microwells |
| 04/15/2010 | WO2010040758A1 Device and method for carrying out a plurality of multiplex flow-through pcr reactions |
| 04/15/2010 | WO2010040756A1 Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6 |
| 04/15/2010 | WO2010040648A2 Functional layers of biomolecules and living cells, and a novel system to produce such |
| 04/15/2010 | WO2010040515A1 Method for identifying gene-activating active substances |
| 04/15/2010 | WO2010040446A1 Estrogen and anti-estrogen marker genes |
| 04/15/2010 | WO2010040374A1 Method for determining the resistance status of fungi and yeasts, in particular of aspergillus fumigatus |
| 04/15/2010 | WO2010040365A1 Method for identifying an increased susceptibility to ulcerative colitis |
| 04/15/2010 | WO2010040278A1 Method for detection of analyte in microarray of samples and apparatus for performing such method |
| 04/15/2010 | WO2010040234A1 Methods for the classification and diagnosis of scoliosis |
| 04/15/2010 | WO2010040233A1 Methods for classifying samples based on network modularity |
| 04/15/2010 | WO2010040204A1 Detection of granulosa-cell tumors |
| 04/15/2010 | WO2010022391A9 Integrated, automated system for the study of cell and tissue function |
| 04/15/2010 | WO2010019921A3 Biomarkers for diagnosis and treatment of chronic lymphocytic leukemia |
| 04/15/2010 | WO2010018563A3 Compositions and methods for the prognosis of lymphoma |
| 04/15/2010 | WO2010018349A3 Culture medium enabling the differentiation of staphylococcus aureus from coagulase-negative staphylococci |
| 04/15/2010 | WO2010017932A4 Proofreading primer extension |
| 04/15/2010 | WO2010011440A3 Diagnosis and treatment of lipogenic adenovirus infection associated with adipose tissue hypertrophy |
| 04/15/2010 | WO2010007255A3 Method for purifying nucleic acids from microorganisms present in liquid samples |
| 04/15/2010 | WO2010006318A3 Electrophoretically enhanced detection of analytes on a solid support |
| 04/15/2010 | WO2010004052A3 Agonists of nr2f6 for immunosuppression |